Clinical experience with Neurox used in patients with cerebrovascular disease

The paper presents the results of an open-label study of ethylmethylhydroxypyridine succinate (Neurox) used as a component of combination therapy in 32 patients with cerebrovascular diseases (CVD): 10 patients have experienced ischemic stroke and 22 have suffered from dyscirculatory encephalopathy....

Full description

Bibliographic Details
Main Authors: N. G. Mayorova, V. A. Pavlov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2011-03-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/77